PlumX Metrics
Embed PlumX Metrics

Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: A single center experience

Haematologica, ISSN: 0390-6078, Vol: 79, Issue: 3, Page: 225-232
1994
  • 6
    Citations
  • 0
    Usage
  • 11
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Background. Both rhGM-CSF and rhG-CSF can accelerate hematological recovery after high-dose therapy and autologous bone marrow transplantation in patients with high grade non Hodgkin's lymphoma and reduce transplant-related morbidity after ABMT. Methods. The clinical course of 23 non randomized patients was analyzed and compared with a historical control group of 10 patients. Ten patients received GM-CSF at a dose of 10 μg/kg in a 6-h IV infusion, and 13 received G-CSF at a dose of 5 μg/kg subcutaneously. Control patients received no GFs. Results. Mean granulocytic recovery to 0.5 x 10/L was obtained 13.1 ± 3.2 days after marrow reinfusion in the G-CSF arm vs 16 ± 2.7 in GM-CSF pts (p = 0.03) and vs 19.6 ± 7.6 in controls (p < 0.01); this reduction led to a statistically significant shorter duration of fever and parenteral antibiotic therapy. Platelet recovery to 20 x 10/L was not significantly influenced by GFs. Conclusions. These results indicate that only G-CSF accelerates hematological recovery after high-dose chemotherapy and autologous bone marrow transplantation and induces a significant decrease in terms of infection morbidity and duration of hospital stay.

Bibliographic Details

M. C. Miggiano; F. Gherlinzoni; G. Visani; A. Belardinelli; P. Ricci; G. Rosti; P. Mazza; M. R. Motta; S. Rizzi; R. M. Lemoli; P. L. Zinzani; S. Tura

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know